| scholarly article | Q13442814 |
| P50 | author | Steven T. DeKosky | Q7615308 |
| Howard J Aizenstein | Q42374777 | ||
| Lewis Kuller | Q88077314 | ||
| Eric McDade | Q90246730 | ||
| P2093 | author name string | William E Klunk | |
| Lisa Weissfeld | |||
| James T Becker | |||
| Beth Snitz | |||
| Oscar L Lopez | |||
| Julie Price | |||
| Chester Mathis | |||
| Milos Ikonomovic | |||
| Ann Cohen | |||
| Rhaven L Coleman | |||
| P2860 | cites work | Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study | Q39613391 | ||
| Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. | Q40415499 | ||
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | Q43062420 | ||
| Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. | Q48166982 | ||
| The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. | Q48256830 | ||
| Risk factors for dementia in the cardiovascular health cognition study | Q48395439 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| White matter hyperintensities predict amyloid increase in Alzheimer's disease | Q48618404 | ||
| Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe | Q49117935 | ||
| Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. | Q49125001 | ||
| White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic. | Q51889308 | ||
| Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. | Q53316825 | ||
| “Mini-mental state” | Q25938989 | ||
| Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
| In vivo assessment of amyloid-β deposition in nondemented very elderly subjects | Q30412704 | ||
| Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. | Q30433809 | ||
| Ginkgo biloba for prevention of dementia: a randomized controlled trial | Q30437036 | ||
| High consistency of regional cortical thinning in aging across multiple samples | Q30489836 | ||
| Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease | Q33560183 | ||
| Amyloid imaging in mild cognitive impairment subtypes. | Q33689424 | ||
| Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. | Q33697980 | ||
| Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment | Q33822960 | ||
| Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). | Q33935314 | ||
| Diffusion alterations in corpus callosum of patients with HIV. | Q33984510 | ||
| Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults | Q34311853 | ||
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease | Q34606557 | ||
| A fully automated method for quantifying and localizing white matter hyperintensities on MR images | Q35568739 | ||
| Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old | Q35606753 | ||
| Incidence and prevalence of dementia in the Cardiovascular Health Study | Q35631591 | ||
| Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease | Q35948528 | ||
| An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease | Q36650399 | ||
| Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. | Q36684239 | ||
| Frequent amyloid deposition without significant cognitive impairment among the elderly | Q37085957 | ||
| Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people | Q37129672 | ||
| Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease | Q37181302 | ||
| Mild cognitive impairment due to Alzheimer disease in the community | Q37245465 | ||
| Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity | Q37291586 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| neurodegeneration | Q1755122 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1804-1811 | |
| P577 | publication date | 2014-10-10 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old | |
| P478 | volume | 83 |
| Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
| Q89626412 | Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia |
| Q88475507 | Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality |
| Q47980580 | Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia |
| Q58129974 | Apolipoproteins and Alzheimer's pathophysiology |
| Q92921065 | Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals |
| Q39189440 | Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. |
| Q40769474 | Cardiovascular disease and dementia risk: an ever growing problem in an aging population |
| Q35999988 | Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways. |
| Q57459490 | MRI load of cerebral microvascular lesions and neurodegeneration, cognitive decline, and dementia |
| Q52589491 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. |
| Q36553735 | Risk of dementia and death in the long-term follow-up of the Pittsburgh Cardiovascular Health Study-Cognition Study |
| Q38373457 | Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly |
| Q35940991 | Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults |
| Q35998525 | Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease |
| Q40665766 | White matter integrity, hippocampal volume, and cognitive performance of a world-famous nonagenarian track-and-field athlete |
Search more.